OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Arbidol targeting influenza virus A Hemagglutinin; A comparative study
Alhassan Ali Ahmed, Mohamed Abouzid
Biophysical Chemistry (2021) Vol. 277, pp. 106663-106663
Closed Access | Times Cited: 16
Alhassan Ali Ahmed, Mohamed Abouzid
Biophysical Chemistry (2021) Vol. 277, pp. 106663-106663
Closed Access | Times Cited: 16
Showing 16 citing articles:
Telehealth and Artificial Intelligence Insights into Healthcare during the COVID-19 Pandemic
Dina M. El‐Sherif, Mohamed Abouzid, Mohamed Tarek Elzarif, et al.
Healthcare (2022) Vol. 10, Iss. 2, pp. 385-385
Open Access | Times Cited: 94
Dina M. El‐Sherif, Mohamed Abouzid, Mohamed Tarek Elzarif, et al.
Healthcare (2022) Vol. 10, Iss. 2, pp. 385-385
Open Access | Times Cited: 94
Influenza antivirals and their role in pandemic preparedness
Jeremy C. Jones, Hui‐Ling Yen, Peter Adams, et al.
Antiviral Research (2022) Vol. 210, pp. 105499-105499
Open Access | Times Cited: 45
Jeremy C. Jones, Hui‐Ling Yen, Peter Adams, et al.
Antiviral Research (2022) Vol. 210, pp. 105499-105499
Open Access | Times Cited: 45
Emerging roles of the Protein Phosphatase 1 (PP1) in the context of viral infections
Pedro O. Corda, Mathieu Bollen, Daniela Ribeiro, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Pedro O. Corda, Mathieu Bollen, Daniela Ribeiro, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants
Mohamed Abouzid, Alhassan Ali Ahmed, Dina M. El‐Sherif, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1270-1270
Open Access | Times Cited: 20
Mohamed Abouzid, Alhassan Ali Ahmed, Dina M. El‐Sherif, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1270-1270
Open Access | Times Cited: 20
Fighting the flu: a brief review on anti-influenza agents
Sambuddha Chakraborty, Ashwini Chauhan
Biotechnology and Genetic Engineering Reviews (2023) Vol. 40, Iss. 2, pp. 858-909
Closed Access | Times Cited: 11
Sambuddha Chakraborty, Ashwini Chauhan
Biotechnology and Genetic Engineering Reviews (2023) Vol. 40, Iss. 2, pp. 858-909
Closed Access | Times Cited: 11
Molecular Modeling of Viral Type I Fusion Proteins: Inhibitors of Influenza Virus Hemagglutinin and the Spike Protein of Coronavirus
Sophia S. Borisevich, Владимир В. Зарубаев, Д. Н. Щербаков, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 902-902
Open Access | Times Cited: 7
Sophia S. Borisevich, Владимир В. Зарубаев, Д. Н. Щербаков, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 902-902
Open Access | Times Cited: 7
Influenza virus cell entry and targeted antiviral development
Murong Zhu, Varada Anirudhan, Ruikun Du, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Closed Access | Times Cited: 4
Murong Zhu, Varada Anirudhan, Ruikun Du, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Closed Access | Times Cited: 4
Maximizing network capacity, control and management in designing a telemedicine network: A review and recent challenges
Bashir Olaniyi Sadiq, Sikiru Olayinka Zakariyya, Mohammed Dahiru Buhari, et al.
Nigerian Journal of Technology (2024) Vol. 43, Iss. 1, pp. 80-100
Open Access
Bashir Olaniyi Sadiq, Sikiru Olayinka Zakariyya, Mohammed Dahiru Buhari, et al.
Nigerian Journal of Technology (2024) Vol. 43, Iss. 1, pp. 80-100
Open Access
MAXIMIZING NETWORK CAPACITY, CONTROL AND MANAGEMENT IN DESIGNING A TELEMEDICINE NETWORK: A REVIEW AND RECENT CHALLENGES
Bashir Olaniyi Sadiq, Sikiru Olayinka Zakariyya, Mohammed Dahiru Buhari, et al.
(2024)
Open Access
Bashir Olaniyi Sadiq, Sikiru Olayinka Zakariyya, Mohammed Dahiru Buhari, et al.
(2024)
Open Access
Greenway of Digital Health Technology During COVID-19 Crisis: Bibliometric Analysis, Challenges, and Future Perspective
Dina M. El‐Sherif, Alhassan Ali Ahmed, Asmaa Fady Sharif, et al.
Advances in experimental medicine and biology (2024), pp. 315-334
Closed Access
Dina M. El‐Sherif, Alhassan Ali Ahmed, Asmaa Fady Sharif, et al.
Advances in experimental medicine and biology (2024), pp. 315-334
Closed Access
Influenza B Virus: Target and acting mechanism of antiviral drugs
Jicheng Han, Chunhui Yang, Yan Xiao, et al.
Microbial Pathogenesis (2024) Vol. 197, pp. 107051-107051
Closed Access
Jicheng Han, Chunhui Yang, Yan Xiao, et al.
Microbial Pathogenesis (2024) Vol. 197, pp. 107051-107051
Closed Access
Synthesis and biological evaluation of substituted quinolines containing piperazine moieties against Influenza A virus
Hongxuan Li, Jian‐Yuan Zhao, Feng Jiang, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130081-130081
Closed Access
Hongxuan Li, Jian‐Yuan Zhao, Feng Jiang, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130081-130081
Closed Access
Understanding the conformational changes in the influenza B M2 ion channel at various protonation states
Unmesh D. Chowdhury, B. L. Bhargava
Biophysical Chemistry (2022) Vol. 289, pp. 106859-106859
Closed Access | Times Cited: 3
Unmesh D. Chowdhury, B. L. Bhargava
Biophysical Chemistry (2022) Vol. 289, pp. 106859-106859
Closed Access | Times Cited: 3
Popular Influenza Antiviral Drugs: Mechanisms, Efficacy, and Resistance
Sidney Ley
(2023)
Open Access | Times Cited: 1
Sidney Ley
(2023)
Open Access | Times Cited: 1
